Premium
Nano‐immunoengineering: Nanoparticle‐Based Manipulation of Antigen‐Presenting Cells for Cancer Immunotherapy (Small 41/2015)
Author(s) -
Fang Ronnie H.,
Kroll Ashley V.,
Zhang Liangfang
Publication year - 2015
Publication title -
small
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.785
H-Index - 236
eISSN - 1613-6829
pISSN - 1613-6810
DOI - 10.1002/smll.201570249
Subject(s) - adjuvant , antigen , nanoparticle , antigen presentation , cancer immunotherapy , dendritic cell , immunotherapy , cell , cross presentation , antigen presenting cell , cell membrane , materials science , immune system , nanotechnology , t cell , chemistry , biophysics , microbiology and biotechnology , immunology , medicine , biology , biochemistry
On page 5483, L. Zhang and co‐workers describe the process of nanoparticle‐mediated antigen presentation. A dendritic cell takes up cell membrane‐coated nanoparticles that are loaded with an immunological adjuvant. After uptake, the tumor antigens on the nanoparticle‐stabilized membrane are processed and presented on the surface of the dendritic cell. Meanwhile, the adjuvant is released and causes the dendritic cell to mature, ultimately enabling it to activate tumor antigen‐specific T cells (shown here as green).